1. Home
  2. CSTL vs VEL Comparison

CSTL vs VEL Comparison

Compare CSTL & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$33.05

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Logo Velocity Financial Inc.

VEL

Velocity Financial Inc.

HOLD

Current Price

$15.34

Market Cap

765.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
VEL
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
722.8M
765.5M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
CSTL
VEL
Price
$33.05
$15.34
Analyst Decision
Strong Buy
Hold
Analyst Count
9
3
Target Price
★ $45.22
$20.83
AVG Volume (30 Days)
★ 319.5K
184.0K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 43.98
EPS
N/A
★ 1.21
Revenue
★ $344,229,000.00
N/A
Revenue This Year
$8.49
N/A
Revenue Next Year
$10.44
$17.51
P/E Ratio
★ N/A
$12.56
Revenue Growth
★ 3.66
N/A
52 Week Low
$17.72
$14.18
52 Week High
$44.28
$21.40

Technical Indicators

Market Signals
Indicator
CSTL
VEL
Relative Strength Index (RSI) 47.52 49.74
Support Level $31.44 $15.09
Resistance Level $34.23 $17.99
Average True Range (ATR) 1.69 0.44
MACD -0.13 0.17
Stochastic Oscillator 21.52 90.68

Price Performance

Historical Comparison
CSTL
VEL

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

About VEL Velocity Financial Inc.

Velocity Financial Inc is a United States-based real estate finance company. Company operates in a large fragmented market with substantial demand for financing and limited supply of institutional financing alternative The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.

Share on Social Networks: